Question 1

What is the company's focus?

Accepted Answer

Sumitomo Pharma America (SMPA) is focused on improving the health and well-being of people around the world. They drive innovative treatments, science, and technology to address patient needs in the critical areas of psychiatry & neurology, oncology, urology, women's health, rare disease, and cell & gene therapy.

Question 2

What is the company's approach to drug discovery and development?

Accepted Answer

SMPA believes that drug discovery, development, and commercialization must become faster and more efficient to address humanity's health needs. The company embodies the bold promise of combining technology and life-sciences expertise to measurably improve patient outcomes.

Question 3

What is the status of SMPA's pipeline?

Accepted Answer

SMPA has a diverse pipeline of preclinical and clinical programs spanning numerous modalities and indications where patient needs remain high or unmet. The company's technology-driven approach is fueling breakthroughs and delivering patient-first solutions sooner.

Question 4

What is the company's history and ownership?

Accepted Answer

SMPA is a U.S. subsidiary of Sumitomo Pharma Co., Ltd., a global pharmaceutical company. Sumitomo Pharma Co., Ltd. and its trademarks are used under license by SMPA.

Question 5

Where can I find more information about SMPA?

Accepted Answer

Visitors can learn more about SMPA and its activities on the company's website, which includes sections on the company's newsroom, leadership, science focus areas, pipeline, clinical trials, products, technology, and impact.

Sumitomo Pharma America, Inc.

Company Overview

Company Name

Address

Website

Phone

About Sumitomo Pharma America, Inc.

Frequently Asked Questions about Sumitomo Pharma America, Inc.

What is the company's focus?

What is the company's approach to drug discovery and development?

What is the status of SMPA's pipeline?

What is the company's history and ownership?

Where can I find more information about SMPA?

Social Profiles

Key Decision Makers